Patient Monitoring Devices Market: China, India and the Chronic Disease Wave

0
3

The patient monitoring devices market was valued at USD 54.3 billion in 2025. It is projected to grow from USD 58.9 billion in 2026 to USD 118.2 billion by 2033, a CAGR of 10.5%. North America led with a 34.9% revenue share in 2025, cardiac monitoring is the largest product segment, and Asia Pacific is the fastest-growing region.

Key Market Statistics & Projections

The Growth Curve

Between 2026 and 2033, the patient monitoring devices market is set to roughly double, since USD 118.2 billion is about 2.0 times the USD 58.9 billion estimated for 2026. The 10.5% CAGR is the number most often quoted. The stronger signal is the demand behind it: continuous, connected measurement of blood pressure, temperature and blood oxygen saturation is moving from a hospital specialty to a standard of care.

Where the Revenue Sits

North America’s 34.9% share is anchored by the U.S. There the CDC reports over 805,000 heart attacks a year, and IQVIA expects more than 142 million Americans (nearly 40% of the population) to use remote patient monitoring technology by 2030. Asia Pacific is growing fastest, helped by the large diabetic populations of China and India. China also has about 100 million people living with COPD, almost 25% of global cases according to WHO. Europe is growing steadily. In July 2024, NICE approved Boston Scientific’s HeartLogic and Medtronic’s TriageHF for heart failure, with hospitalizations reduced by up to 72%.

The figures in this article draw on Grand View Research’s market analysis. Continue your research with their Prism AI tool for more data and insights.

Core Product Segments

Cardiac Monitoring Leads, but Nobody Dominates

Cardiac monitoring devices held the largest product share at 14.8% in 2025. Cardiovascular disease remains the leading cause of death worldwide, and AI-enabled arrhythmia detection and wireless ECG patches have lifted adoption. Cardinal Health’s Kendall DL Multi System, launched in June 2025, shows where design is heading: one single-use device tracking cardiac activity, oxygen saturation and temperature.

A leading share below 15% is itself a finding. The category spans blood glucose, multi-parameter, respiratory, temperature, hemodynamic, fetal and neonatal, neuromonitoring and weight monitoring, and no single branch carries it.

Download a free sample report or claim your copy of this full market intelligence report

The Fastest Movers

Wearable drug delivery systems are expected to post the fastest CAGR, driven by self-administered therapy for diabetes, oncology and autoimmune conditions. In glucose monitoring, the FDA-cleared Dexcom G7 15 Day CGM offers up to 15.5 days of wear and an 8.0% MARD. By end use, hospitals held the largest share in 2025 because multiparameter monitors track vitals across wards and ICUs. Home care is the fastest-growing setting as devices become smaller, more precise and more portable.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs

Key Industry Players

The competitive field is highly fragmented. Companies profiled by Grand View Research include Bosch, Biotronik, Welch Allyn, Koninklijke Philips N.V., GE Healthcare, Medtronic, Masimo, Smiths Medical, OMRON, Mindray, F. Hoffmann-La Roche, Drägerwerk, Nihon Kohden and Natus Medical.

The report’s benchmarking contrasts two profiles. Philips is a mature player whose strength is hospital relationships and distribution, but premium pricing and long procurement cycles limit its reach in cost-sensitive markets. Natus is an emerging player competing on affordable, portable, wireless devices, though with a thinner distribution network and lower brand recognition.

Partnerships are the preferred growth tool. In July 2025, Medtronic and Philips agreed to integrate Nellcor pulse oximetry, Microstream capnography and BIS brain monitoring into Philips platforms. In April 2024, Philips and smartQare joined to connect Healthdot and viQtor biosensors across hospital and home. In May 2024, OMRON Healthcare India and AliveCor introduced AI-driven portable ECG devices, including the first FDA-cleared device combining blood pressure and ECG in India.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Major Market Drivers & Trends

Demand-Side Forces

Demographics and disease burden set the baseline. WHO estimates that by 2030 one in six people globally will be aged 60 or older, and 1.4 billion adults aged 30–79 had hypertension in 2024, about 33% of that age group. Clinicians are also on board: the AMA’s 2022 study found 93% of physicians view digital tools as beneficial, with remote patient monitoring usage more than doubling to 30% since 2016. Tele-ICU is a further accelerant, seen in HealthNet Global’s April 2024 program at Apollo Spectra Hospitals and the GE HealthCare–Medanta e-ICU in India, launched in July 2023.

AI and the Alarm Problem

AI is the clearest opportunity. Roche’s Accu-Chek SmartGuide CGM received CE mark approval in July 2024 with predictive algorithms that forecast hypoglycemia. BD’s HemoSphere Alta, launched in April 2025, adds hypotension prediction for critical care. The main restraint is alarm fatigue, where non-actionable alerts desensitize ICU staff. Data security concerns, reimbursement gaps, the FDA’s 2023 cybersecurity guidance and EU MDR requirements add cost and lengthen approval timelines.

Analyst Takeaways

These are interpretations drawn from the report’s data, not figures from it.

First, platforms are starting to matter more than single devices. With no segment above 15% share, the Medtronic–Philips deal suggests buyers want validated, bundled ecosystems rather than isolated monitors.

Second, alarm fatigue may be where AI proves its value. If predictive tools cut non-actionable alerts, the biggest restraint in the patient monitoring devices market becomes a selling point.

Third, the hospital-to-home handoff is the real contest. Hospitals lead today, yet home care and wearable drug delivery are the fastest-growing areas, so the winners will keep data continuous across both settings.

Check Out Our Dedicated Business Offerings –

U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today

Suche
Kategorien
Mehr lesen
Andere
AI in Government and Public Services Market Forecast to Reach USD 160.0 Billion by 2036 at 17.8% CAGR
NEWARK, Del., United States — September 16, 2026 — The global AI in Government and...
Von vvvvai 2026-09-16 09:50:20 0 246
Andere
Global In-Mold Label Market Growing at 6.7% CAGR Through 2034
According to a new report from Intel Market Research, the global In-Mold Label market was valued...
Von Subhayan2 2026-06-10 11:40:30 0 5KB
Startseite
Airbnb Revenue Management in Dubai: Maximise Your Rental Income with Prospera UAE
The growing demand for holiday homes in Dubai creates excellent opportunities for property...
Von Technova 2026-11-13 09:44:31 0 244
Andere
Custom Swimming Pool Maintenance Tips for Long-Lasting Performance
Owning a custom pool comes with ongoing maintenance responsibilities that, while not...
Von farede 2026-08-11 08:11:33 0 564
Food
Fox Nuts Market Projected to Grow at 8.4% CAGR Over the Forecast Period
Market Estimation & Definition The global Fox Nuts Market is gaining traction as...
Von Shwetajadhav123 2026-09-16 05:53:57 0 818